Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: An untargeted approach via high-resolution mass spectrometry

Journal of Proteome Research

Volumn 12, Issue 8, 2013, Pages 3746-3754

  Blasco, Hélène ^a,b,c   Corcia, Philippe ^a,b   Pradat, Pierre François ^d   Bocca, Cinzia ^b   Gordon, Paul H ^d   Veyrat Durebex, Charlotte ^a,b,c   Mavel, Sylvie ^a,b   Nadal Desbarats, Lydie ^a,b,c   Moreau, Caroline ^e   Devos, David ^e   Andres, Christian R ^a,b,c   Emond, Patrick ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c CHU BRETONNEAU   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIV LILLE   (France)

Author keywords

ALS; amyotrophic lateral sclerosis; biomarkers; cerebrospinal fluid; CSF; LC HRMS; mass spectrometry; metabolomics

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROSPRAY; FEMALE; FOURIER TRANSFORM MASS SPECTROMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; PRIORITY JOURNAL; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84881181817     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400376e     Document Type: Article

References (45)

1. Andersen, P. M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene Curr. Neurol. Neurosci. Rep. 2006, 6 (1) 37-46
2. Shaw, P. J. Molecular and cellular pathways of neurodegeneration in motor neurone disease J. Neurol. Neurosurg. Psychiatry 2005, 76 (8) 1046-1057
3. Rocchetti, I.; Taruscio, D.; Pierannunzio, D. Modeling delay to diagnosis for amiotrophic lateral sclerosis: under reporting and incidence estimates BMC Neurol. 2012, 12 (1) 160
4. Benatar, M.; Wuu, J. Presymptomatic studies in ALS: rationale, challenges, and approach Neurology 2012, 79 (16) 1732-1739
5. Mitchell, R. M.; Freeman, W. M.; Randazzo, W. T.; Stephens, H. E.; Beard, J. L.; Simmons, Z.; Connor, J. R. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis Neurology 2009, 72 (1) 14-19
6. Sussmuth, S. D.; Brettschneider, J.; Ludolph, A. C.; Tumani, H. Biochemical markers in CSF of ALS patients Curr. Med. Chem. 2008, 15 (18) 1788-1801
7. Tumani, H.; Teunissen, C.; Sussmuth, S.; Otto, M.; Ludolph, A. C.; Brettschneider, J. Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases Expert Rev. Mol. Diagn. 2008, 8 (4) 479-494
8. Patti, G. J.; Yanes, O.; Siuzdak, G. Innovation: Metabolomics: the apogee of the omics trilogy Nat. Rev. Mol. Cell Biol. 2012, 13 (4) 263-269
9. Wang, J. H.; Byun, J.; Pennathur, S. Analytical approaches to metabolomics and applications to systems biology Semin. Nephrol. 2010, 30 (5) 500-511
10. Quinones, M. P.; Kaddurah-Daouk, R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases Neurobiol. Dis. 2009, 35 (2) 165-176
11. Rozen, S.; Cudkowicz, M. E.; Bogdanov, M.; Matson, W. R.; Kristal, B. S.; Beecher, C.; Harrison, S.; Vouros, P.; Flarakos, J.; Vigneau-Callahan, K.; Matson, T. D.; Newhall, K. M.; Beal, M. F.; Brown, R. H.; Kaddurah-Daouk, R. Metabolomic analysis and signatures in motor neuron disease Metabolomics 2005, 1 (2) 101-108
12. Babu, G. N.; Kumar, A.; Bala, L.; Kalita, J.; Misra, U. K.; Singh, R. L.; Khetrapal, C. L. Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis Clin. Chim. Acta 2010, 411, 1383
13. Ala-Korpela, M. Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool Expert Rev. Mol. Diagn. 2007, 7 (6) 761-773
14. Blasco, H.; Corcia, P.; Moreau, C.; Veau, S.; Fournier, C.; Vourc'h, P.; Emond, P.; Gordon, P.; Pradat, P. F.; Praline, J.; Devos, D.; Nadal-Desbarats, L.; Andres, C. R. 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis PLoS One 2010, 5 (10 e13223
15. Lawton, K. A.; Cudkowicz, M. E.; Brown, M. V.; Alexander, D.; Caffrey, R.; Wulff, J. E.; Bowser, R.; Lawson, R.; Jaffa, M.; Milburn, M. V.; Ryals, J. A.; Berry, J. D. Biochemical alterations associated with ALS Amyotrophic Lateral Scler. 2012, 13 (1) 110-118
16. Wuolikainen, A.; Moritz, T.; Marklund, S. L.; Antti, H.; Andersen, P. M. Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS PLoS One 2011, 6 (4 e17947
17. Wuolikainen, A.; Andersen, P. M.; Moritz, T.; Marklund, S. L.; Antti, H. ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations Mol. Genet. Metab. 2012, 105 (3) 472-478
18. Novakova, L.; Matysova, L.; Solich, P. Advantages of application of UPLC in pharmaceutical analysis Talanta 2006, 68 (3) 908-918
19. Theodoridis, G. A.; Gika, H. G.; Want, E. J.; Wilson, I. D. Liquid chromatography-mass spectrometry based global metabolite profiling: a review Anal. Chim. Acta 2012, 711, 7-16
20. Wang, X.; Sun, H.; Zhang, A.; Wang, P.; Han, Y. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies J. Sep. Sci. 2011, 34 (24) 3451-9
21. Ming, X.; Stein, T. P.; Barnes, V.; Rhodes, N.; Guo, L. Metabolic perturbance in autism spectrum disorders: a metabolomics study J. Proteome Res. 2012, 11 (12) 5856-5862
22. Brooks, B. R.; Miller, R. G.; Swash, M.; Munsat, T. L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis Amyotrophic Lateral Scler. Other Mot. Neuron Disord. 2000, 1 (5) 293-299
23. Wuolikainen, A.; Hedenstrom, M.; Moritz, T.; Marklund, S. L.; Antti, H.; Andersen, P. M. Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS Amyotrophic Lateral Scler. 2009, 10 (4) 229-236
24. Rosenling, T.; Stoop, M. P.; Smolinska, A.; Muilwijk, B.; Coulier, L.; Shi, S.; Dane, A.; Christin, C.; Suits, F.; Horvatovich, P. L.; Wijmenga, S. S.; Buydens, L. M.; Vreeken, R.; Hankemeier, T.; van Gool, A. J.; Luider, T. M.; Bischoff, R. The impact of delayed storage on the measured proteome and metabolome of human cerebrospinal fluid Clin. Chem. 2011, 57 (12) 1703-1711
25. Vuckovic, D. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry Anal. Bioanal. Chem. 2012, 403 (6) 1523-1548
26. Crews, B.; Wikoff, W. R.; Patti, G. J.; Woo, H. K.; Kalisiak, E.; Heideker, J.; Siuzdak, G. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data Anal. Chem. 2009, 81 (20) 8538-8544
27. Polson, C.; Sarkar, P.; Incledon, B.; Raguvaran, V.; Grant, R. Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2003, 785 (2) 263-275
28. Spagou, K.; Wilson, I. D.; Masson, P.; Theodoridis, G.; Raikos, N.; Coen, M.; Holmes, E.; Lindon, J. C.; Plumb, R. S.; Nicholson, J. K.; Want, E. J. HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies Anal. Chem. 2011, 83 (1) 382-390
29. Kamleh, M. A.; Ebbels, T. M.; Spagou, K.; Masson, P.; Want, E. J. Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies Anal. Chem. 2012, 84 (6) 2670-2677
30. Kemsley, E. K.; Le Gall, G.; Dainty, J. R.; Watson, A. D.; Harvey, L. J.; Tapp, H. S.; Colquhoun, I. J. Multivariate techniques and their application in nutrition: a metabolomics case study Br. J. Nutr. 2007, 98 (1) 1-14
31. Madsen, R.; Lundstedt, T.; Trygg, J. Chemometrics in metabolomics - a review in human disease diagnosis Anal. Chim. Acta 2010, 659 (1-2) 23-33
32. Westerhuis, J. A.; van Velzen, E. J.; Hoefsloot, H. C.; Smilde, A. K. Multivariate paired data analysis: multilevel PLSDA versus OPLSDA Metabolomics 2010, 6 (1) 119-128
33. Peskind, E. R.; Riekse, R.; Quinn, J. F.; Kaye, J.; Clark, C. M.; Farlow, M. R.; Decarli, C.; Chabal, C.; Vavrek, D.; Raskind, M. A.; Galasko, D. Safety and acceptability of the research lumbar puncture Alzheimer Dis. Assoc. Disord. 2005, 19 (4) 220-225
34. Wishart, D. S.; Lewis, M. J.; Morrissey, J. A.; Flegel, M. D.; Jeroncic, K.; Xiong, Y.; Cheng, D.; Eisner, R.; Gautam, B.; Tzur, D.; Sawhney, S.; Bamforth, F.; Greiner, R.; Li, L. The human cerebrospinal fluid metabolome J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2008, 871 (2) 164-173
35. Wishart, D. S.; Jewison, T.; Guo, A. C.; Wilson, M.; Knox, C.; Liu, Y.; Djoumbou, Y.; Mandal, R.; Aziat, F.; Dong, E.; Bouatra, S.; Sinelnikov, I.; Arndt, D.; Xia, J.; Liu, P.; Yallou, F.; Bjorndahl, T.; Perez-Pineiro, R.; Eisner, R.; Allen, F.; Neveu, V.; Greiner, R.; Scalbert, A. HMDB 3.0 - The Human Metabolome Database in 2013 Nucleic Acids Res. 2013, 41 (D1) D801-807
36. Courant, F.; Royer, A. L.; Chereau, S.; Morvan, M. L.; Monteau, F.; Antignac, J. P.; Le Bizec, B. Implementation of a semi-automated strategy for the annotation of metabolomic fingerprints generated by liquid chromatography-high resolution mass spectrometry from biological samples Analyst 2012, 137 (21) 4958-4967
37. Hoffmann, N.; Keck, M.; Neuweger, H.; Wilhelm, M.; Hogy, P.; Niehaus, K.; Stoye, J. Combining peak- and chromatogram-based retention time alignment algorithms for multiple chromatography-mass spectrometry datasets BMC Bioinf. 2012, 13, 214
38. Eliasson, M.; Rannar, S.; Madsen, R.; Donten, M. A.; Marsden-Edwards, E.; Moritz, T.; Shockcor, J. P.; Johansson, E.; Trygg, J. Strategy for optimizing LC-MS data processing in metabolomics: a design of experiments approach Anal. Chem. 2012, 84 (15) 6869-6876
39. Kirwan, G. M.; Johansson, E.; Kleemann, R.; Verheij, E. R.; Wheelock, A. M.; Goto, S.; Trygg, J.; Wheelock, C. E. Building multivariate systems biology models Anal. Chem. 2012, 84 (16) 7064-7071
40. Mandal, R.; Guo, A. C.; Chaudhary, K. K.; Liu, P.; Yallou, F. S.; Dong, E.; Aziat, F.; Wishart, D. S. Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update Genome Med. 2012, 4 (4) 38
41. van den Berg, R. A.; Hoefsloot, H. C.; Westerhuis, J. A.; Smilde, A. K.; van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data BMC Genomics 2006, 7, 142
42. Krug, S.; Kastenmuller, G.; Stuckler, F.; Rist, M. J.; Skurk, T.; Sailer, M.; Raffler, J.; Romisch-Margl, W.; Adamski, J.; Prehn, C.; Frank, T.; Engel, K. H.; Hofmann, T.; Luy, B.; Zimmermann, R.; Moritz, F.; Schmitt-Kopplin, P.; Krumsiek, J.; Kremer, W.; Huber, F.; Oeh, U.; Theis, F. J.; Szymczak, W.; Hauner, H.; Suhre, K.; Daniel, H. The dynamic range of the human metabolome revealed by challenges FASEB J. 2012, 26 (6) 2607-2619
43. Spreux-Varoquaux, O.; Bensimon, G.; Lacomblez, L.; Salachas, F.; Pradat, P. F.; Le Forestier, N.; Marouan, A.; Dib, M.; Meininger, V. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients J. Neurol. Sci. 2002, 193 (2) 73-78
44. Shaw, P. J.; Forrest, V.; Ince, P. G.; Richardson, J. P.; Wastell, H. J. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients Neurodegeneration 1995, 4 (2) 209-216
45. Rothstein, J. D.; Tsai, G.; Kuncl, R. W.; Clawson, L.; Cornblath, D. R.; Drachman, D. B.; Pestronk, A.; Stauch, B. L.; Coyle, J. T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis Ann. Neurol. 1990, 28 (1) 18-25